Požymis
Decreased arm strength
Klinikinis pavadinimas: Upper limb muscle weakness
Weakness of the muscles of the arms.
Santrauka
- Taip pat vadinama
- Weak arm
Read the genes linked to Decreased arm strength, and the rest of your genome, with one test.
Nuo 449 $Nemokamas pristatymas · Rezultatai per 6–8 savaites
Įsigyti savo Genome Test93 genų susiję su Decreased arm strength
Šių genų pakitimai sukelia retas ligas, kuriose pasireiškia Decreased arm strength. Dauguma žmonių, turinčių šį požymį, neturi nė vienos iš tų ligų, o šiame sąraše esantis genas nieko nesako apie kieno nors paties genomą.
| Genas | Kaip dažnai pasireiškia | Ligos |
|---|---|---|
| ARHGAP19Rho GTPase activating protein 19 | Visada | 1 ligoje |
| CFL2cofilin 2 | Visada | 1 ligoje |
| CHRNA1cholinergic receptor nicotinic alpha 1 subunit | Visada | 1 ligoje |
| DSTdystonin | Visada | 1 ligoje |
| IGHMBP2immunoglobulin mu DNA binding protein 2 | Visada | 1 ligoje |
| KLC4kinesin light chain 4 | Visada | 1 ligoje |
| LMNAlamin A/C | Visada | 2 ligose |
| NDC1NDC1 transmembrane nucleoporin | Visada | 1 ligoje |
| PDXKpyridoxal kinase | Visada | 1 ligoje |
| SBF1SET binding factor 1 | Visada | 1 ligoje |
| SPTAN1spectrin alpha, non-erythrocytic 1 | Visada | 2 ligose |
| NEFLneurofilament light chain | Labai dažnai (80–99%) | 1 ligoje |
| SEPTIN9septin 9 | Labai dažnai (80–99%) | 1 ligoje |
| TFGtrafficking from ER to golgi regulator | Labai dažnai (80–99%) | 1 ligoje |
| ANGangiogenin | Dažnai (30–79%) | 1 ligoje |
| ANXA11annexin A11 | Dažnai (30–79%) | 1 ligoje |
| ATXN2ataxin 2 | Dažnai (30–79%) | 1 ligoje |
| BSCL2BSCL2 lipid droplet biogenesis associated, seipin | Dažnai (30–79%) | 1 ligoje |
| CCNFcyclin F | Dažnai (30–79%) | 1 ligoje |
| CFAP410cilia and flagella associated protein 410 | Dažnai (30–79%) | 1 ligoje |
| CHCHD10coiled-coil-helix-coiled-coil-helix domain containing 10 | Dažnai (30–79%) | 1 ligoje |
| CHMP2Bcharged multivesicular body protein 2B | Dažnai (30–79%) | 1 ligoje |
| COL25A1collagen type XXV alpha 1 chain | Dažnai (30–79%) | 1 ligoje |
| DAOD-amino acid oxidase | Dažnai (30–79%) | 1 ligoje |
| DCTN1dynactin subunit 1 | Dažnai (30–79%) | 1 ligoje |
| ERBB4erb-b2 receptor tyrosine kinase 4 | Dažnai (30–79%) | 1 ligoje |
| ERGIC1endoplasmic reticulum-golgi intermediate compartment 1 | Dažnai (30–79%) | 1 ligoje |
| FIG4FIG4 phosphoinositide 5-phosphatase | Dažnai (30–79%) | 1 ligoje |
| FUSFUS RNA binding protein | Dažnai (30–79%) | 1 ligoje |
| GARS1glycyl-tRNA synthetase 1 | Dažnai (30–79%) | 3 ligose |
| GDAP1ganglioside induced differentiation associated protein 1 | Dažnai (30–79%) | 1 ligoje |
| GLE1GLE1 RNA export mediator | Dažnai (30–79%) | 1 ligoje |
| GLT8D1glycosyltransferase 8 domain containing 1 | Dažnai (30–79%) | 1 ligoje |
| GYG1glycogenin 1 | Dažnai (30–79%) | 1 ligoje |
| HEXBhexosaminidase subunit beta | Dažnai (30–79%) | 1 ligoje |
| HNRNPA1heterogeneous nuclear ribonucleoprotein A1 | Dažnai (30–79%) | 1 ligoje |
| INPP4Ainositol polyphosphate-4-phosphatase type I A | Dažnai (30–79%) | 1 ligoje |
| KIF5Akinesin family member 5A | Dažnai (30–79%) | 1 ligoje |
| LRP12LDL receptor related protein 12 | Dažnai (30–79%) | 2 ligose |
| MATR3matrin 3 | Dažnai (30–79%) | 1 ligoje |
Rodyti dar 53 genų
| Genas | Kaip dažnai pasireiškia | Ligos |
|---|---|---|
| MORC2MORC family CW-type zinc finger 2 | Dažnai (30–79%) | 1 ligoje |
| MTRFRmitochondrial translation release factor in rescue | Dažnai (30–79%) | 2 ligose |
| NEFHneurofilament heavy chain | Dažnai (30–79%) | 2 ligose |
| NEK1NIMA related kinase 1 | Dažnai (30–79%) | 1 ligoje |
| OPTNoptineurin | Dažnai (30–79%) | 1 ligoje |
| PFN1profilin 1 | Dažnai (30–79%) | 1 ligoje |
| PIEZO2piezo type mechanosensitive ion channel component 2 | Dažnai (30–79%) | 1 ligoje |
| PRPHperipherin | Dažnai (30–79%) | 1 ligoje |
| REEP1receptor accessory protein 1 | Dažnai (30–79%) | 1 ligoje |
| SCYL2SCY1 like pseudokinase 2 | Dažnai (30–79%) | 1 ligoje |
| SGCGsarcoglycan gamma | Dažnai (30–79%) | 1 ligoje |
| SOD1superoxide dismutase 1 | Dažnai (30–79%) | 1 ligoje |
| SPARTspartin | Dažnai (30–79%) | 1 ligoje |
| SQSTM1sequestosome 1 | Dažnai (30–79%) | 1 ligoje |
| TAF15TATA-box binding protein associated factor 15 | Dažnai (30–79%) | 1 ligoje |
| TARDBPTAR DNA binding protein | Dažnai (30–79%) | 1 ligoje |
| TBK1TANK binding kinase 1 | Dažnai (30–79%) | 1 ligoje |
| TREM2triggering receptor expressed on myeloid cells 2 | Dažnai (30–79%) | 1 ligoje |
| UBQLN2ubiquilin 2 | Dažnai (30–79%) | 1 ligoje |
| UNC13Aunc-13 homolog A | Dažnai (30–79%) | 1 ligoje |
| VAPBVAMP associated protein B and C | Dažnai (30–79%) | 2 ligose |
| VCPvalosin containing protein | Dažnai (30–79%) | 1 ligoje |
| ZFYVE26zinc finger FYVE-type containing 26 | Dažnai (30–79%) | 1 ligoje |
| ADARadenosine deaminase RNA specific | Kartais (5–29%) | 1 ligoje |
| AKT1AKT serine/threonine kinase 1 | Kartais (5–29%) | 1 ligoje |
| B4GALNT1beta-1,4-N-acetyl-galactosaminyltransferase 1 | Kartais (5–29%) | 1 ligoje |
| BAP1BRCA1 associated deubiquitinase 1 | Kartais (5–29%) | 1 ligoje |
| CCND1cyclin D1 | Kartais (5–29%) | 1 ligoje |
| CYP7B1cytochrome P450 family 7 subfamily B member 1 | Kartais (5–29%) | 2 ligose |
| GALCgalactosylceramidase | Kartais (5–29%) | 2 ligose |
| MT-ATP6mitochondrially encoded ATP synthase membrane subunit 6 | Kartais (5–29%) | 1 ligoje |
| NF2NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor | Kartais (5–29%) | 1 ligoje |
| NUP54nucleoporin 54 | Kartais (5–29%) | 1 ligoje |
| NUP62nucleoporin 62 | Kartais (5–29%) | 1 ligoje |
| PDGFBplatelet derived growth factor subunit B | Kartais (5–29%) | 1 ligoje |
| PIK3CAphosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | Kartais (5–29%) | 1 ligoje |
| POU3F4POU class 3 homeobox 4 | Kartais (5–29%) | 1 ligoje |
| RAB3ARAB3A, member RAS oncogene family | Kartais (5–29%) | 1 ligoje |
| SMARCB1SWI/SNF related BAF chromatin remodeling complex subunit B1 | Kartais (5–29%) | 1 ligoje |
| SMARCE1SWI/SNF related BAF chromatin remodeling complex subunit E1 | Kartais (5–29%) | 1 ligoje |
| SMOsmoothened, frizzled class receptor | Kartais (5–29%) | 1 ligoje |
| SPG7SPG7 matrix AAA peptidase subunit, paraplegin | Kartais (5–29%) | 2 ligose |
| SUFUSUFU negative regulator of hedgehog signaling | Kartais (5–29%) | 1 ligoje |
| TERTtelomerase reverse transcriptase | Kartais (5–29%) | 1 ligoje |
| TRAF7TNF receptor associated factor 7 | Kartais (5–29%) | 1 ligoje |
| TUBA4Atubulin alpha 4a | Kartais (5–29%) | 1 ligoje |
| VHLvon Hippel-Lindau tumor suppressor | Kartais (5–29%) | 1 ligoje |
| DNMT3BDNA methyltransferase 3 beta | Neužfiksuota | 1 ligoje |
| EGR2early growth response 2 | Neužfiksuota | 2 ligose |
| FGD4FYVE, RhoGEF and PH domain containing 4 | Neužfiksuota | 1 ligoje |
| MPZmyelin protein zero | Neužfiksuota | 2 ligose |
| SH3TC2SH3 domain and tetratricopeptide repeats 2 | Neužfiksuota | 1 ligoje |
| YARS1tyrosyl-tRNA synthetase 1 | Neužfiksuota | 1 ligoje |
Kaip dažnai šis požymis pasitaiko žmonėms, turintiems vieną iš geno sukeliamų ligų, ir kuris dažnis tarp jų didžiausias, pagal Žmogaus fenotipo ontologijos duomenis. Šiuose puslapiuose aprašomi požymiai ir juos grindžiantys tyrimai; tai nėra diagnozė, o su simptomais kreipkitės į gydytoją ar genetikos konsultantą.
Siauresni požymiai
Platesni požymiai
Iš kur tai žinoma
- Žmogaus fenotipo ontologija, 2026-09-01 leidimas: požymis, jo pavadinimai, apibrėžimas ir su juo susiję genai. Daugiau sužinokite svetainėje hpo.jax.org.
- Duomenų leidimas 2026.10.16-c6eea6bf.
Vienas testas. Atsakymai visam gyvenimui.
Nuo 449 $Nemokamas pristatymas · Rezultatai per 6–8 savaites